BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 1414241)

  • 1. Six-year follow-up study on the efficacy and safety of vigabatrin in patients with epilepsy.
    Tartara A; Manni R; Galimberti CA; Morini R; Mumford JP; Iudice A; Perucca E
    Acta Neurol Scand; 1992 Sep; 86(3):247-51. PubMed ID: 1414241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vigabatrin in intractable childhood epilepsy: a retrospective study.
    Gibbs JM; Appleton RE; Rosenbloom L
    Pediatr Neurol; 1992; 8(5):338-40. PubMed ID: 1418176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vigabatrin: a three year clinical analysis.
    Martin PJ; Millac PA
    Seizure; 1993 Jun; 2(2):137-40. PubMed ID: 8167965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vigabatrin in chronic epilepsy: a 7-year follow-up study of responder patients.
    Cocito L; Maffini M; Loeb C
    Seizure; 1993 Dec; 2(4):301-7. PubMed ID: 8162400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vigabatrin and lamotrigin: experiences with 2 new anticonvulsants in the Swiss epilepsy clinic].
    Vogt H; Krämer G
    Schweiz Med Wochenschr; 1995 Jan; 125(4):125-32. PubMed ID: 7878401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vigabatrin in drug-resistant partial epilepsy: a 5-year follow-up study.
    Sivenius J; Ylinen A; Murros K; Mumford JP; Riekkinen PJ
    Neurology; 1991 Apr; 41(4):562-5. PubMed ID: 1901397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-response study of vigabatrin in children with refractory epilepsy.
    Herranz JL; Arteaga R; Farr IN; Valdizan E; Beaumont D; Armijo JA
    J Child Neurol; 1991; Suppl 2():S45-51. PubMed ID: 1940124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of vigabatrin in the long-term treatment of refractory epilepsy.
    Remy C; Beaumont D
    Br J Clin Pharmacol; 1989; 27 Suppl 1(Suppl 1):125S-129S. PubMed ID: 2757903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vigabatrin in adults with poorly-controlled epilepsy and learning disabilities.
    Armour DJ; Fidler C; Wright EC; Balarajan S
    Seizure; 1992 Sep; 1(3):157-62. PubMed ID: 1344760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-blind, placebo-controlled multicenter trial of vigabatrin in the treatment of epilepsy. The Italian Study Group on Vigabatrin.
    Ital J Neurol Sci; 1992 Dec; 13(9):741-7. PubMed ID: 1483856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term antiepileptic efficacy of vigabatrin in drug-refractory epilepsy in mentally retarded patients. A 5-year follow-up study.
    Pitkänen A; Ylinen A; Matilainen R; Luukkainen R; Mervaala E; Seppänen R; Ruutiainen T; Riekkinen PJ
    Arch Neurol; 1993 Jan; 50(1):24-9. PubMed ID: 8418797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vigabatrin use in 72 patients with drug-resistant epilepsy.
    Buchanan N
    Seizure; 1994 Sep; 3(3):191-6. PubMed ID: 8000713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vigabatrin in the treatment of epilepsy in children.
    Livingston JH; Beaumont D; Arzimanoglou A; Aicardi J
    Br J Clin Pharmacol; 1989; 27 Suppl 1(Suppl 1):109S-112S. PubMed ID: 2757901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vigabatrin in the treatment of epilepsy: a long-term follow-up study.
    Tartara A; Manni R; Galimberti CA; Mumford JP; Iudice A; Perucca E
    J Neurol Neurosurg Psychiatry; 1989 Apr; 52(4):467-71. PubMed ID: 2661725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basic mechanisms of seizure propagation: targets for rational drug design and rational polypharmacy.
    Löscher W; Ebert U
    Epilepsy Res Suppl; 1996; 11():17-43. PubMed ID: 9294726
    [No Abstract]   [Full Text] [Related]  

  • 17. Gamma-vinyl GABA (vigabatrin) in epilepsy: clinical, neurochemical, and neurophysiologic monitoring in epileptic patients.
    Ylinen A; Sivenius J; Pitkänen A; Halonen T; Partanen J; Mervaala E; Mumford JP; Riekkinen PJ
    Epilepsia; 1992; 33(5):917-22. PubMed ID: 1396436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A survey comparing lamotrigine and vigabatrin in everyday clinical practice.
    Schapel G; Chadwick D
    Seizure; 1996 Dec; 5(4):267-70. PubMed ID: 8952011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute encephalopathy with vigabatrin.
    Sälke-Kellermann A; Baier H; Rambeck B; Boenigk HE; Wolf P
    Lancet; 1993 Jul; 342(8864):185. PubMed ID: 8101289
    [No Abstract]   [Full Text] [Related]  

  • 20. Double-blind study of vigabatrin in the treatment of drug-resistant epilepsy.
    Tassinari CA; Michelucci R; Ambrosetto G; Salvi F
    Arch Neurol; 1987 Sep; 44(9):907-10. PubMed ID: 2887152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.